Pilonidal Disease — Off-Midline Doctrine, Flap Equivalence and Laser-Epilation Recurrence Control

Definition and manifestations — tailor, never stage

Pilonidal sinus is hair-follicle sepsis of the buttock cleft, with an estimated incidence of 26 per 100,000 affecting men twice as often as women.^[3] Every case splits into one of three German-guideline manifestations — asymptomatic disease, an acute abscess, or chronic pilonidal disease.^[1] No single method is simple, painless, fast-healing and low-recurrence all at once, so modality is tailored to manifestation and extent.^[1] There is no examined staging system in this evidence set: examine by manifestation and extent, never by a named stage.^[1][38]

Risk factors — the 219-fold combination

A prospective case-control study (587 patients, 2,780 healthy controls) ranks three predictors above all others: stiffness of body hair (adjusted odds ratio 9.23), number of baths (6.33) and time spent seated per day (4.03), with body-mass index adding an odds ratio of 1.3.^[6] The combination is the counsel: hairy people who sit more than six hours a day and bathe twice a week or less carry a 219-fold increased risk versus those without these factors.^[6] Family history did not differ between groups and no specific occupation was implicated.^[6] After excision with primary closure, surgical-site infection runs 12.8%, with smoking and obesity as independent risks — so non-obese non-smokers may be closed while smokers and obese patients should stop smoking, lose weight, or be laid open instead.^[7]

Asymptomatic and mild disease — the no-resection pathway

Asymptomatic disease needs no treatment in both the 2016 and 2020 German guidelines.^[1][2] For mild adolescent disease there is a no-resection pathway: improved hygiene plus pit excision under local anaesthesia plus laser epilation resolved 77 of 78 followed cases after a mean of 3 laser sessions and 1.3 pit excisions over 30 weeks, with minimal morbidity and no activity restrictions.^[39] The paediatric surgical consensus agrees with the direction: minimal procedures such as the Gips procedure and sinusectomy suit first-line use over radical excision for their faster recovery, patient preference and acceptable recurrence.^[33]

Acute abscess — unroof or aspirate, then treat definitively

A pilonidal abscess should be unroofed or incised — and after resolution of the acute inflammation, the disease should be treated definitely, never left to the abscess procedure alone.^[1][2] In selected patients (not septic, immunocompromised or diabetic, without skin necrosis or perforation), needle aspiration under local anaesthetic with empirical antibiotics converts the emergency into an elective case: 38 of 40 resolved with return to normal activities the next day and 95% effectiveness in the pilot series, with day-case excision and primary closure at a median of 9 weeks for those proceeding.^[8] The larger cohort (100 aspirated of 169 presenting) holds at 83% effectiveness with overall-satisfaction visual-analogue score 9, and only 10 needing later incision and drainage at a median of 29 months.^[9] Emergency-medicine guidance concurs: needle aspiration with antibiotics may be a suitable alternative to incision and drainage for pilonidal abscess.^[10]

Open healing versus primary closure — the Cochrane trade

Cochrane 2010 (26 trials, 2,530 patients) prices the fundamental trade: healing is faster after surgical closure than open healing, surgical-site infection does not differ, but recurrence is lower with open healing (relative risk 0.60).^[3] The BMJ meta-analysis (18 trials, 1,573 patients) agrees — recurrence relative risk 0.42 after open healing, with 14 wounds needing open healing to prevent one recurrence.^[5] The 2025 chronic-disease review (50 trials, 5,762 participants) adds the flap qualifier: flaps beat primary midline closure on recurrence (odds ratio 0.31), but flap-versus-secondary-healing did not reach significance (odds ratio 0.38, p = 0.08) — and secondary healing always takes longest.^[18] Honesty requires the outlier: one 77-patient randomised trial found operating time, stay, time off work and healing all highly significantly favouring closure with fewer total complications — short follow-up against the long-term hierarchy above.^[51]

Midline versus off-midline — the closure doctrine

When closure is chosen, off-midline closure is the standard — and the 2024 Cochrane review (33 studies, 3,667 analysed participants, median age 21 to 34, male predominant) is the number set to memorise: healing 5.23 days faster, recurrence 1.5% against 6.8% (relative risk 0.22), infection 3.8% against 11.7% (relative risk 0.32), dehiscence 3.9% against 8.9% (relative risk 0.44), and return to work 3.72 days earlier — all against conventional midline closure.^[4] The NNT translation: 9 patients treated off-midline to prevent one infection, 11 to prevent one recurrence — with midline infection risk multiplied 4.70-fold and recurrence odds 4.95-fold.^[5] Both German guidelines therefore abandon midline closure as obsolete, and the technique meta-analysis (25 trials, 2,949 patients) buries open radical excision with primary midline closure alongside it.^[1][2][17] One nuance survives: a 150-patient three-arm trial found 6% recurrence with Limberg, 6% with Karydakis and 4% with tension-free primary closure — its conclusion being that a tension-free healing side matters more than whether the suture line sits on the midline.^[20]

Karydakis versus Limberg — equivalence with two asterisks

State the equivalence first, because five pooled analyses agree: the RCT-only review finds no significant differences between Limberg and Karydakis techniques.^[11] Eight randomised trials (554 Karydakis against 567 Limberg) show recurrence odds ratio 1.07 with no other significant differences beyond seroma.^[12] Five classical-flap trials (727 patients) agree — recurrence, dehiscence, infection and haematoma all non-significant.^[15] Fifteen trials (1,943 patients) find overall complications and failure of healing equivalent, and the 2024 Cochrane Karydakis-Limberg slice finds recurrence 5.1% against 4.5% (relative risk 1.14).^[14][4] Guidelines concur: the two best-described methods carry similar short- and long-term results.^[1]

Then price the two asterisks. Karydakis is about 7 minutes quicker per case.^[11] But seroma clusters with Karydakis — lower with Limberg (odds ratio 2.03) across 8 trials, higher with Karydakis (odds ratio 2.33) across 15, with higher wound infection too (odds ratio 1.87) — partly offset by slightly earlier return to work and higher satisfaction scores.^[12][14] The bedside limitation decides more often than the statistics: with laterally situated orifices the Karydakis method may not apply, while complication, stay and recurrence rates are otherwise indistinguishable in the 145-patient three-centre randomised trial.^[13] With no outcome differences between off-midline procedures, the choice follows surgeon expertise, patient characteristics and patient preference.^[2][4][18]

Technique hierarchy — limited beats radical, sinusectomy beats closure, flaps beat suture

Rank the excisions: limited beats radical open on every outcome except recurrence, where they tie.^[17] Sinusectomy or sinotomy beats primary closure on recurrence with no other differences.^[17] Rank the closures: flaps beat direct suture on recurrence, incapacity duration, infections, skin complications and hospital stay — and beat lay-open on healing time and incapacity.^[19] The rhomboid-flap meta-analysis (641 patients, 331 flaps) trends the same way: less recurrence (p = 0.07) with lower infection (p = 0.001) and dehiscence (p = 0.01), no difference in pain, stay or return to work.^[43] The sacrococcygeal review (27 articles, 54 studies, 3,612 participants) is blunter: midline closure recurs 6.15-fold against Limberg and 12.70-fold against marsupialisation, open healing recurs 6.04-fold against Karydakis, and midline infects 4.14-fold against Limberg.^[44] Karydakis against conventional surgery (15 studies, 3,108) cuts recurrence against midline closure (odds ratio 0.30) and against secondary healing (0.29), with earlier return to work by 6.5 and 18.9 days respectively.^[45] The network verdict across 39 studies and 5,061 patients: modified Limberg flap and off-midline closure carry the lowest recurrence.^[16]

Minimally invasive excision — pit picking, Gips, Bascom I and cleft lift

Pit picking is the guideline-sanctioned minimal option for small primary disease — with the explicit warning that its recurrence exceeds excision procedures or open healing.^[1][2] In children, Gips beats en-bloc resection: equal re-intervention (10.87% against 7.14%) with healing in 3.31 against 6.13 months and zero against 65.22% dehiscence.^[36] The Danish Bascom-I cohort (3,555 patients, 79% male, 2010–2021) is the mandatory reality check on minimal surgery: 30% 5-year re-operation risk, highest in younger patients, 65% of re-operations within 12 months — and 45% after a second Bascom I — with early failures driving the number, so selection, technique and training must improve.^[21] The cleft lift prices the durable end of the spectrum: 66 of 70 healed within 6 weeks, median 2 weeks off work and 4 to normal activities, with no recurrence among 47 surveyed at median 24 months — against 14 patients with complications (8 breakdowns, 5 infections, 4 seromas, 1 early recurrence).^[22] Across 1,200 cleft lifts the infection price is 3.3% (39 infections), and 37 of 39 healed without revision on antibiotics with drainage maintained.^[23] For recurrent disease after prior surgery, incision with curettage of granulation, hair and debris in 42 patients took 16.6 minutes, healed in 19.9 days and showed zero recurrences at 3 years.^[49]

Endoscopic and laser ablation — fast recovery, short-term evidence

Endoscopic pilonidal sinus treatment heals 94.2% with 1.2% recurrence in 86 patients — back to daily activities in a median of 1 day and work in 3, with no wound complications — but 5 of 6 failures carried more than 3 midline pits, which marks the selection boundary.^[27] The video-assisted pilot (27 patients) previews the same promise: 1 recurrence at 1 year with immediate return to work and high satisfaction.^[56] Adding laser to endoscopy (SiLaC with EPSiT, 83 patients) runs 25 minutes with pain score 1.2 at 24 hours, 92.3% back within a day, healing in 17.3 days with 95% epithelialised by 3 weeks, and 3.6% recurrence at 6 months against 1.2% minor infections.^[29] The indirect meta-analysis (29 studies) finds the two laser-endoscopic options comparable — cure 86% against 88%, recurrence 11% against 9%, complications 10% against 7%, healing 30 against 27 days — while stressing that no direct comparative trial exists.^[28] Laser-assisted endoscopy matches plain endoscopy on healing (95.8% against 93%) with shorter operating and closure times, less pain and better cosmesis — at higher hospital cost.^[48] Standalone radial-laser ablation heals 94.4% with 3.8% recurrence and 10% all-minor complications — but strictly in mild chronic disease.^[30] For recurrent disease, pooled laser-ablation healing is 81.9%, falling to 74.5% beyond 12 months.^[40] A 48-patient 1470-nm series heals 100% in 28.3 days with 2.1% recurrence, near-zero pain scores and return to normal life in 7.1 days.^[47] The endoscopic literature (34 articles) confirms painless recovery, short time off work and high satisfaction — with long-term recurrence data still needed, and Italian-guideline gold-standard status confined to limited disease.^[46] Technique is still heterogenous enough that the International Society of Laser Proctology issued 10 position statements to homogenise SiLaC alone and combined with EPSiT.^[57] The viva boundary: minimally invasive approaches suit selected primary cases but are not equivalent to flap surgery in complex or recurrent disease on current long-term evidence.^[38]

Laser epilation — the recurrence adjunct with an RCT

The JAMA randomised trial (302 adolescents and young adults, 151 per arm) is the anchor: laser epilation plus standard care cut 1-year recurrence by 23.2 absolute points against standard care alone, with no differences in disability days, quality of life, satisfaction, stigma, procedures or complications — and laser should be available as an initial or adjunct option for all eligible patients.^[24] Three randomised trials pooled give a recurrence odds ratio of 0.319 for laser epilation.^[25] Across 14 studies (963 patients), recurrence runs 9.3% after laser against 23.4% after razor or cream and 19.7% after nothing.^[26] The wider literature (35 studies) ranges 0 to 28% recurrence at 6 months to 5 years, with 4 of 5 comparative studies favouring laser.^[50] Controlled slices agree: 8.3% against 51.7% in the French case-control study, and zero of 15 laser patients against 7 of 10 controls needing further surgery with Nd:YAG.^[55][54] The long tail matters for consent: 13.3% recurrence at mean 4.8 years with three-quarters of recurrences surfacing at 5 to 9 years.^[42] The UK district series holds 12% recurrence at median 172 weeks with better results beyond two sessions and no laser complications.^[53] Laser depilation also costs less per disease-free month than repeated surgery.^[52]

Recurrence arithmetic — benchmark at 5 years, consent the tail

Long-term meta-analysis (15 studies, minimum 5-year follow-up) sets the ladder: 13.8% overall — 17.9% open healing, 16.8% midline closure, 10% off-midline — and demands at least 5-year follow-up as the benchmarking gold standard.^[31] An institutional series warns how follow-up flatters: 26% recurrence at median 20 months rising to 44% 5-year actuarial, worst after lay-open at 56%.^[41] Paediatric pooling (59 studies, 5,075 patients) reproduces the hierarchy: off-midline 10.2% against open 20.1% and midline 17.5%, with midline wound complications at 43.5% and reoperation at 29.8%.^[35] Methylene-blue staining (1,192 studies, 130,677 patients) lowers recurrence across open, midline, asymmetric and Limberg approaches — but the Bascom and Karydakis slices lost follow-up, dulling that limb of the claim.^[37]

Wound complications, PITSTOP pricing and healing timelines

Price open healing honestly: wounds usually heal after a mean of 2 months with almost all healed by 3 months, delayed healing runs 2 to 5%, and any wound unhealed at 3 to 4 months must be re-evaluated with a changed strategy.^[34] Predict the at-risk wound before operating: smoking and obesity are independent infection risks.^[7] PITSTOP (667 patients, 60% major procedures) prices the major-versus-minor choice: major surgery adds 1.58 day-1 and 1.53 day-7 pain points, 17.5% more complications and 34-plus extra healing days with 25.9 extra days off normal activities — buying 10.1% fewer recurrences.^[32] For recurrent or persistent disease, any flap repair is acceptable and preferred by patients over healing by secondary intention.^[33]

Recovery, paediatrics and the exam close

Quote functional recovery by modality: endoscopy returns to activities in 1 day and work in 3; cleft lift takes a median of 2 weeks off work and 4 to normal activities; 1470-nm laser ablation returns to normal life in 7.1 days; combined SiLaC-EPSiT returns 92.3% within 24 hours.^{[27][22][47][29]} In under-18s, off-midline closure and minimally invasive strategies — especially with laser epilation — win on recurrence, complications and recovery, with minimally invasive techniques returning to daily activities in 1 to 3 days at pain scores 0 to 2.^[35] Close every viva with the three never-lines: never close in the midline, never resect asymptomatic disease, never promise endoscopic or laser results in complex or recurrent disease beyond the short-term evidence.^[1][2][38] And confess the gaps the examiners respect: no quality-of-life data in either Cochrane comparison, mostly small short trials at high or medium bias, and long-term minimally-invasive recurrence still missing.^[4][18][46]

Revision summary

Hair-follicle sepsis of young adults splits three ways — leave the asymptomatic, unroof or aspirate the abscess then treat definitively, excise the chronic with the smallest adequate operation.^[1][3][8] Close off-midline or not at all: 5.23 faster days, recurrence 1.5% against 6.8%, infection 3.8% against 11.7%, NNTs 9 and 11.^[4][5] Karydakis equals Limberg on recurrence — 7 minutes quicker, more seroma, lateral orifices excepted, expertise deciding.^{[11][12][13][18]} Minimal surgery for small primary disease carries a 30% Bascom re-operation tail; flaps own the complex and recurrent.^[21][33] Endoscopy and laser ablate fast in selected primary disease; laser epilation cuts recurrence by 23 absolute points as standard adjunct.^[27][29][24] Benchmark recurrence at 5 years — 13.8% overall, 10% off-midline — and price every wound by smoking, obesity and the 2-month healing clock.^[31][7][34]

References57ShowHide

1. [1]Iesalnieks I, Ommer A, Herold A, et al. German National Guideline on the management of pilonidal disease: update 2020. Langenbecks Arch Surg, 2021.PMID 33950407
2. [2]Iesalnieks I, Ommer A, Petersen S, et al. German national guideline on the management of pilonidal disease. Langenbecks Arch Surg, 2016.PMID 27311698
3. [3]Al-Khamis A, McCallum I, King PM, et al. Healing by primary versus secondary intention after surgical treatment for pilonidal sinus. Cochrane Database Syst Rev, 2010.PMID 20091589
4. [4]Cai Z, Zhao Z, Ma Q, et al. Midline and off-midline wound closure methods after surgical treatment for pilonidal sinus. Cochrane Database Syst Rev, 2024.PMID 38226663
5. [5]McCallum IJ, King PM, Bruce J Healing by primary closure versus open healing after surgery for pilonidal sinus: systematic review and meta-analysis. BMJ, 2008.PMID 18390914
6. [6]Harlak A, Mentes O, Kilic S, et al. Sacrococcygeal pilonidal disease: analysis of previously proposed risk factors. Clinics (Sao Paulo), 2010.PMID 20186294
7. [7]Al-Khayat H, Al-Khayat H, Sadeq A, et al. Risk factors for wound complication in pilonidal sinus procedures. J Am Coll Surg, 2007.PMID 17765160
8. [8]Hussain ZI, Aghahoseini A, Alexander D Converting emergency pilonidal abscess into an elective procedure. Dis Colon Rectum, 2012.PMID 22595842
9. [9]Lasithiotakis K, Aghahoseini A, Volanaki D, et al. Aspiration for acute pilonidal abscess-a cohort study. J Surg Res, 2018.PMID 29433863
10. [10]Menegas S, Moayedi S, Torres M Abscess Management: An Evidence-Based Review for Emergency Medicine Clinicians. J Emerg Med, 2021.PMID 33298356
11. [11]Gavriilidis P, Bota E Limberg flap versus Karydakis flap for treating pilonidal sinus disease: a systematic review and meta-analysis. Can J Surg, 2019.PMID 30697992
12. [12]Prassas D, Rolfs TM, Schumacher FJ, et al. Karydakis flap reconstruction versus Limberg flap transposition for pilonidal sinus disease: a meta-analysis of randomized controlled trials. Langenbecks Arch Surg, 2018.PMID 30066108
13. [13]Can MF, Sevinc MM, Hancerliogullari O, et al. Multicenter prospective randomized trial comparing modified Limberg flap transposition and Karydakis flap reconstruction in patients with sacrococcygeal pilonidal disease. Am J Surg, 2010.PMID 20122682
14. [14]Emile SH, Khan SM, Barsom SH, et al. Karydakis procedure versus Limberg flap for treatment of pilonidal sinus: an updated meta-analysis of randomized controlled trials. Int J Colorectal Dis, 2021.PMID 33839888
15. [15]Sahebally SM, McMahon G, Walsh SR, et al. Classical Limberg versus classical Karydakis flaps for pilonidal disease- an updated systematic review and meta-analysis of randomized controlled trials. Surgeon, 2019.PMID 30145045
16. [16]Bi S, Sun K, Chen S, et al. Surgical procedures in the pilonidal sinus disease: a systematic review and network meta-analysis. Sci Rep, 2020.PMID 32792519
17. [17]Enriquez-Navascues JM, Emparanza JI, Alkorta M, et al. Meta-analysis of randomized controlled trials comparing different techniques with primary closure for chronic pilonidal sinus. Tech Coloproctol, 2014.PMID 24845110
18. [18]Wiinblad IM, Ulrichsen J, Brandstrup B Outcome After Surgical Treatment for Chronic Pilonidal Sinus Disease: A Systematic Review of Common Surgical Techniques. Dis Colon Rectum, 2025.PMID 39982788
19. [19]Berthier C, Bérard E, Meresse T, et al. A comparison of flap reconstruction vs the laying open technique or excision and direct suture for pilonidal sinus disease: A meta-analysis of randomised studies. Int Wound J, 2019.PMID 31230414
20. [20]Sevinç B, Karahan Ö, Okuş A, et al. Randomized prospective comparison of midline and off-midline closure techniques in pilonidal sinus surgery. Surgery, 2016.PMID 26531235
21. [21]Faurschou IK, Erichsen R, Haas S Risk of re-operation after Bascom I for pilonidal sinus disease. A Danish population-based cohort study. Colorectal Dis, 2026.PMID 42227065
22. [22]Abdelrazeq AS, Rahman M, Botterill ID, et al. Short-term and long-term outcomes of the cleft lift procedure in the management of nonacute pilonidal disorders. Dis Colon Rectum, 2008.PMID 18470564
23. [23]Immerman SC Wound Infection After Cleft Lift Operation for Pilonidal Disease. Cureus, 2025.PMID 39925508
24. [24]Minneci PC, Gil LA, Cooper JN, et al. Laser Epilation as an Adjunct to Standard Care in Reducing Pilonidal Disease Recurrence in Adolescents and Young Adults: A Randomized Clinical Trial. JAMA Surg, 2024.PMID 37938854
25. [25]Muscat N, Gupta A, Arifuzaman M, et al. Preventing Pilonidal Sinus Recurrence With Laser Hair Epilation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Cureus, 2024.PMID 39036233
26. [26]Pronk AA, Eppink L, Smakman N, et al. The effect of hair removal after surgery for sacrococcygeal pilonidal sinus disease: a systematic review of the literature. Tech Coloproctol, 2018.PMID 29185064
27. [27]Gulcu B, Ozturk E Endoscopic Pilonidal Sinus Treatment: Rapid Recovery, Satisfactory Success, and High Quality of Life. Surg Laparosc Endosc Percutan Tech, 2021.PMID 34310558
28. [28]Li Z, Jin L, Ouali M, et al. A systematic review and meta-analysis of sinus laser associated closure (SiLaC) versus endoscopic pilonidal sinus treatment (EPSiT) in the management of pilonidal sinus disease. Langenbecks Arch Surg, 2026.PMID 41964736
29. [29]Ouali M SiLaC® with EPSiT®: early outcomes of laser-endoscopic therapy for pilonidal sinus. Front Surg, 2025.PMID 40352310
30. [30]Romic I, Augustin G, Bogdanic B, et al. Laser treatment of pilonidal disease: a systematic review. Lasers Med Sci, 2022.PMID 34291332
31. [31]Milone M, Velotti N, Manigrasso M, et al. Long-term follow-up for pilonidal sinus surgery: A review of literature with metanalysis. Surgeon, 2018.PMID 29699781
32. [32]Brown S, Hind D, Strong E, et al. Treatment options for patients with pilonidal sinus disease: PITSTOP, a mixed-methods evaluation. Health Technol Assess, 2024.PMID 39045854
33. [33]Grabowski J, Oyetunji TA, Goldin AB, et al. The management of pilonidal disease: A systematic review. J Pediatr Surg, 2019.PMID 30948198
34. [34]Petersen S, Ommer A, Iesalnieks I, et al. [Wound Healing Disorders after Excision and Open Treatment for Pilonidal Sinus]. Zentralbl Chir, 2021.PMID 33336345
35. [35]Saleem MM, Usmani SUR, Hashmi MR, et al. Surgical management of pilonidal sinus disease in pediatric population: An updated systematic review and meta-analysis. J Pediatr Surg, 2026.PMID 41999968
36. [36]Diéguez I, Costa A, Miró I, et al. En bloc resection vs. Gips procedure in pilonidal sinus surgery. Cir Pediatr, 2022.PMID 35485755
37. [37]Maak M, Oetzmann von Sochaczewski C, Hackmann T, et al. The Use of Methylene Blue in Pilonidal Sinus Surgery Reduces the Risk of Recurrence: A Systematic Review and Meta-Analysis. Medicina (Kaunas), 2026.PMID 41752637
38. [38]Matteucci M, Zampino L, Barone G, et al. The New Minimally Invasive Techniques for Pilonidal Sinus Disease Surgery: Choosing the Right Technique for the Right Patient-A Narrative Review. Medicina (Kaunas), 2026.PMID 41901600
39. [39]Check NM, Wynne NK, Mooney DP Resolution of Mild Pilonidal Disease in Adolescents Without Resection. J Am Coll Surg, 2022.PMID 36102566
40. [40]Qin J, Xu X, Li Z, et al. Efficacy and safety of laser ablation for recurrent pilonidal sinus: a systematic review and meta-analysis. Int J Colorectal Dis, 2025.PMID 39969579
41. [41]Hølmebakk T, Nesbakken A Surgery for pilonidal disease. Scand J Surg, 2005.PMID 15865116
42. [42]Oram Y, Kahraman F, Karincaoğlu Y, et al. Evaluation of 60 patients with pilonidal sinus treated with laser epilation after surgery. Dermatol Surg, 2010.PMID 20002644
43. [43]Horwood J, Hanratty D, Chandran P, et al. Primary closure or rhomboid excision and Limberg flap for the management of primary sacrococcygeal pilonidal disease? A meta-analysis of randomized controlled trials. Colorectal Dis, 2012.PMID 20969718
44. [44]Wu P, Zhang Y, Zhang Y, et al. Progress in the surgical treatment of sacrococcygeal pilonidal sinus: a review. Int J Surg, 2023.PMID 37158142
45. [45]Alsalaumy AHA Comparative study of the Karydakis flap versus conventional surgical techniques for pilonidal sinus disease: a systematic review and meta-analysis. Updates Surg, 2026.PMID 41854814
46. [46]Manigrasso M, Anoldo P, Cantore G, et al. Endoscopic Treatment of Pilonidal Sinus Disease: State of Art and Review of the Literature. Front Surg, 2021.PMID 35059431
47. [47]Li Z, Jin L, Gong T, et al. An effective and considerable treatment of pilonidal sinus disease by laser ablation. Lasers Med Sci, 2023.PMID 36856904
48. [48]Gulcu B, Ozturk E Endoscopic pilonidal sinus treatment vs. laser-assisted endoscopic pilonidal sinus treatment: short-term results from a retrospective case-matched study. Tech Coloproctol, 2022.PMID 35025023
49. [49]Demir U, Yazici P, Bostanci O, et al. Less is more: "incision and curettage" as an optimal procedure for recurrent pilonidal disease. Ann Ital Chir, 2015.PMID 26900142
50. [50]Halleran DR, Onwuka AJ, Lawrence AE, et al. Laser Hair Depilation in the Treatment of Pilonidal Disease: A Systematic Review. Surg Infect (Larchmt), 2018.PMID 30095368
51. [51]Kareem TS Surgical treatment of chronic sacrococcygeal pilonidal sinus. Open method versus primary closure. Saudi Med J, 2006.PMID 17013478
52. [52]Khan MA, Javed AA, Govindan KS, et al. Control of hair growth using long-pulsed alexandrite laser is an efficient and cost effective therapy for patients suffering from recurrent pilonidal disease. Lasers Med Sci, 2016.PMID 27003897
53. [53]Liyanage A, Woods Y, Javed MA, et al. Laser depilation as adjuvant therapy in prevention of recurrence of pilonidal sinus disease: initial experience of a district general hospital in the UK. Ann R Coll Surg Engl, 2020.PMID 32302208
54. [54]Badawy EA, Kanawati MN Effect of hair removal by Nd:YAG laser on the recurrence of pilonidal sinus. J Eur Acad Dermatol Venereol, 2009.PMID 19586514
55. [55]Kelati A, Lagrange S, Le Duff F, et al. Laser hair removal after surgery vs. surgery alone for the treatment of pilonidal cysts: a retrospective case-control study. J Eur Acad Dermatol Venereol, 2018.PMID 29633368
56. [56]Milone M, Musella M, Di Spiezio Sardo A, et al. Video-assisted ablation of pilonidal sinus: a new minimally invasive treatment--a pilot study. Surgery, 2014.PMID 24300343
57. [57]Ouali M, Martin-Martin GP, Avdicausevic S, et al. International Society of Laser Proctology Position Paper on SiLaC and EPSiT/SiLaC in the Management of Pilonidal Sinus Disease. Lasers Surg Med, 2025.PMID 41078023